HN2new | past | comments | ask | show | jobs | submitlogin

Great article. Best of luck to them.

Anybody knows about efforts to lower trial phases costs down ? (without lowering quality of course). Any out of the box idea ?



Collaboration - one control arm, 2+ active drugs from multiple companies (why not 6+?). Fewer patients exposed to placebo, less paperwork, same statistical power, more so if you randomise 2:1:1:1:1:1 rather than a standard trial with 1:1 or 2:1




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: